CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...

A red quarter of a circle with the words 'The Quarter Mark' beside it. A year-long series looking back on the most significant moments of the past 25 years, how they changed our world, and how they ...

Being the only Neanderthal raised in a 21st-century world of humans would likely be lonely and isolating, possibly like the ...

Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...

John L. Hennessy is President Emeritus of Stanford University as well as the James F. and Mary Lynn Gibbons Professor of ...

Explore the future technologies transforming industries, from AI advancements to breakthroughs in renewable energy.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

Intellia Therapeutics will find it challenging to survive now that its CRISPR gene-editing treatment has been tied to severe, ...

The company is gene editing crops to make our food supply more resilient to climate change. Climate change will make it increasingly difficult to grow crops across many parts of the world. Pairwise is ...